Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
28.3M
-
Shares change
-
+5.13M
-
Total reported value, excl. options
-
$1.18B
-
Value change
-
+$218M
-
Put/Call ratio
-
0.85
-
Number of buys
-
107
-
Number of sells
-
-60
-
Price
-
$41.74
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2022
200 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q3 2022.
TransMedics Group, Inc. - Common Stock (TMDX) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.3M shares
of 33.9M outstanding shares and own 83.28% of the company stock.
Largest 10 shareholders include FMR LLC (3.94M shares), BlackRock Inc. (2.2M shares), MACQUARIE GROUP LTD (1.75M shares), VANGUARD GROUP INC (1.64M shares), Sandhill Capital Partners LLC (1.34M shares), CREDIT SUISSE AG/ (1.17M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (997K shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (827K shares), NEXT CENTURY GROWTH INVESTORS LLC (804K shares), and LORD, ABBETT & CO. LLC (772K shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.